SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is capturing community attention as a culture-first cryptocurrency on Solana, with supporters emphasizing its focus on global cannabis advocacy and long-term utility beyond typical meme trends. Investors are actively discussing the upcoming 4/20 date as a key catalyst for the project, while debates continue between those committed to the 'culture-led' mission and skeptics focused on recent market performance.

It's a Meme Coin It's worthless? It is: Unicorn Fart Dust Prove me wrong! I am a 54 year old (almost) boomer, 1st time crypto buyer and started this Meme Coin in 3 hours. I will be covering this journey here on my YouTube channel  I was taught that silver and gold are the only forms of real money, everything else is Unicorn Fart Dust. Until proven wrong (this happens often)...............................

Unicorn Fart Dust

The UFD community is rallying around the project's grassroots origins, framing it as a defiant movement to 'mog and mock' traditional systems through memes, community-led initiatives, and upcoming NFT drops. Supporters are actively focused on long-term growth and building a dedicated culture, contrasting their organic approach with what they view as predatory industry practices.

Fervo Energy Co. operates as a energy company. It builds and operates power facilities in extracting geothermal energy. The company was founded by Jack Norbeck and Timothy Latimer in 2017 and is headquartered in Berkeley, CA.

Fervo Energy Co. - Ordinary Shares - Class A

Fervo Energy Co

Fervo Energy is trending following its high-profile Nasdaq debut, as investors debate the long-term potential of its geothermal technology to power AI-driven data centers. The community remains sharply divided between bulls excited by the company's clean energy prospects and backing from major tech partners, and bears expressing skepticism over its valuation given the lack of current revenue.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

MELANIA is currently trending due to intense community debate regarding its status as a high-risk meme coin, with retail traders aggressively arguing over whether it represents a legitimate collection or a pump-and-dump scheme. The conversation is heavily polarized, featuring significant skepticism from critics citing past volatility and the broader, often contentious, association with the Trump family brand.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is experiencing significant price discovery and community excitement, fueled by its growing role as a high-performance decentralized exchange leader and its role in institutional crypto strategies. Investors are actively tracking its momentum, comparing it to established crypto assets, and focusing on its potential for long-term utility within the broader DeFi infrastructure.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell is rallying on the back of strong enterprise AI server demand and a highly publicized endorsement from the White House, fueling a broader sector trend of capital rotation into on-prem infrastructure. The community is actively debating if the stock remains an undervalued AI infrastructure play compared to peers or if the rapid momentum has created a bubble setup prone to volatility ahead of upcoming earnings.

Hyliion Holdings Corp. engages in the development of sustainable electricity-producing technology. It focuses on providing modular power plant technology that can operate on various fuel sources through the KARNO power module. The company was founded by Thomas J. Healy in 2015 and is headquartered in Cedar Park, TX.

Hyliion Holdings Corporation - Ordinary Shares - Class A

Hyliion Holdings Corp

Hyliion is currently driving significant community engagement and speculative momentum following a series of successful milestones, including key UL certification and expanded military partnership prospects that have investors comparing its potential to established AI-infrastructure plays. Market participants are actively debating the company's transition from a research-focused entity to a commercial generator provider, with intense focus on its ability to scale the KARNO power module amidst massive power demand from data centers.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is experiencing high community engagement as traders speculate on future meme coin rallies and discuss potential price action amid broader market volatility. Investors remain divided, with some actively buying dips and pushing for new highs, while others express caution regarding project long-term sustainability.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is seeing intense market volatility as investors weigh the potential of its REZPEG clinical data against concerns regarding trial eligibility and future capital needs. Community sentiment remains polarized, with many shareholders pointing to the drug's novel regulatory T-cell mechanism as a significant, undervalued breakthrough, while others express frustration over management's history of dilution and persistent short-selling pressure.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

Fetch.ai is generating buzz as investors bet on the expansion of autonomous AI agents and the ongoing development of the ASI Alliance infrastructure. While some community members remain focused on long-term accumulation and the potential for a decentralized AI economy, others are debating the coin's recovery potential following recent market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$XERS The story of XP-8121, SubQ Levothyroxine, might eventually be bigger than expected($1-3B  revenue projected by Xeris) + specialty drug margins. Not that it isn&#39;t already outstanding as it is, I&#39;m just reflecting the importance of SubQ Levothyroxine based XeriSol, as the only existing non-oral option globally, without competition, in such a huge market.

Keep in mind that a large number of patients may essentially need it, domestically &amp; globally, in order to normalize their condition -&gt;
Patients after bariatric surgery
Patients w/celiac disease
Patients w/Crohn&#39;s disease 
Patients w/gastroparesis
Patients w/chronic PPI use
Patients w/calcium/iron issues
Patients taking many medications
Elderly patients with compliance issues
Patients needing unusually high oral doses
Patients whose TSH fluctuates constantly

There are also patients who are technically &quot;absorbing&quot; oral levo but:
absorb inconsistently
miss doses
fail to follow the strict fasting requirements.

Global importance.

The Good Inves$tor

David Krav

J. Dionne

Kevin Haborak

Simon C

David Evans

Fred Garcia

StockTwits For Android 

Xeris Biopharma Holdings Inc

 The story of XP-8121, SubQ Levothyroxine, might eventually be bigger than expected($1-3B  revenue projected by Xeris) + specialty drug margins. Not that it isn't already outstanding as it is, I'm just reflecting the importance of SubQ Levothyroxine based XeriSol, as the only existing non-oral option globally, without competition, in such a huge market.

Keep in mind that a large number of patients may essentially need it, domestically & globally, in order to normalize their condition ->
Patients after bariatric surgery
Patients w/celiac disease
Patients w/Crohn's disease 
Patients w/gastroparesis
Patients w/chronic PPI use
Patients w/calcium/iron issues
Patients taking many medications
Elderly patients with compliance issues
Patients needing unusually high oral doses
Patients whose TSH fluctuates constantly

There are also patients who are technically "absorbing" oral levo but:
absorb inconsistently
miss doses
fail to follow the strict fasting requirements.

Global importance.